AAV vectors encoding malarial antigens stimulate antigen-specific immunity but do not protect from parasite infection

Grant J Logan1, Lina Wang, Maolin Zheng

  • 1Gene Therapy Research Unit, Children's Medical Research Institute and The Children's Hospital at Westmead, Westmead, Australia.

Vaccine
|November 4, 2006
PubMed

Insights

Recombinant adeno-associated virus (rAAV) shows potential for genetic vaccines targeting malaria antigens. However, current rAAV delivery alone does not induce protective immunity against Plasmodium yoelii infection.

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Recombinant adeno-associated virus (rAAV) is being investigated as a novel genetic vaccine delivery system.
  • Muscle tissue is a potential target for in vivo genetic vaccination.

Purpose of the Study:

  • To evaluate the efficacy of rAAV as a genetic vaccine delivery system for malaria antigens.
  • To assess the induction of antigen-specific antibody responses and protective immunity.

Main Methods:

  • Single intramuscular injection of rAAV vectors encoding Plasmodium falciparum MSP4 or Plasmodium yoelii MSP4/5 antigens.
  • Assessment of long-term antibody responses and challenge with P. yoelii infection.
  • Evaluation of alternative strategies including DNA priming and AAV boosting.

Main Results:

  • rAAV delivery successfully induced long-term antigen-specific antibody responses against MSP4 and MSP4/5.
  • Immunity generated by AAV against MSP4/5 did not confer protection against P. yoelii challenge.
  • Priming with DNA or AAV, followed by rAAV boosting, failed to enhance protective antibody responses.

Conclusions:

  • While rAAV can elicit antibody responses, it is insufficient for protective anti-malarial immunity in this model.
  • Further strategies, such as incorporating genetic adjuvants into rAAV vectors, are required to achieve adequate protective immunity.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...